An association between plasma free protein S concentration and risk of coronary heart disease in middle-aged men

Thrombosis Research

Volumn 101, Issue 2, 2001, Pages 1-11

  Rudnicka, Alicja R ^a   Miller, George J ^a   Nelson, Toppy ^b   Doray, Deborah ^b   Comp, Philip C ^b  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

^b UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Coronary heart disease; Epidemiology; Protein S

Indexed keywords

CHOLESTEROL; FIBRINOGEN; PLASMA PROTEIN; PROTEIN S; TRIACYLGLYCEROL; VITAMIN K GROUP;

ADULT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; HAZARD; HEART INFARCTION; HIGH RISK POPULATION; HUMAN; IMMUNOASSAY; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MORTALITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN S DEFICIENCY; RISK FACTOR; SUDDEN DEATH;

ANALYSIS OF VARIANCE; COHORT STUDIES; CORONARY DISEASE; HUMANS; IMMUNOASSAY; INCIDENCE; LIPIDS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROTEIN S; RISK FACTORS;

EID: 0035862672     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(00)00379-0     Document Type: Article

References (60)

1. Regulation of activated protein C by a new protein
2. Advances in the etiology and treatment of venous thromboembolism
3. Effects of protein S and factor Xa on peptide bond cleavages during inactivation of factor Va and factor VaR506Q by activated protein C
4. Factor V and protein S as synergistic cofactors to activated protein C in degradation of factor VIIIa
5. Protein S binds to and inhibits factor Xa
6. Binding of protein S to factor Va associated with inhibition of prothrombinase that is independent of activated protein C
7. Familial protein S deficiency is associated with recurrent thrombosis
8. Human protein S inhibits prothrombinase complex activity on endothelial cells and platelets via direct interactions with factors Va and Xa
9. Recurrent venous thromboembolism in patients with a partial deficiency of protein S
10. Hereditary protein S deficiency and venous thromboembolism. A study in three Dutch families
11. Neonatal purpura fulminans associated with homozygous protein S deficiency
12. Hereditary protein S deficiency: Clinical manifestations
13. The Leiden Thrombophilia Study (LETS)
14. Replacement therapy for protein C deficiency using fresh frozen plasma
15. Free protein S deficiency in acute ischemic stroke. A case-control study
16. Deficiency of plasma protein S, protein C or antithrombin III and arterial thrombosis
17. Hereditary protein S deficiency in young adults with arterial occlusive disease
18. Inherited protein S deficiency: Clinical manifestations and laboratory findings in 63 patients
19. Successful delayed thrombolysis with tissue plasminogen activator for recurrent arterial thrombosis secondary to protein S deficiency
20. Functional heredity protein S deficiency with arterial thrombosis
21. Arterial thrombosis and protein S deficiency
22. Myocardial infarction and death after caesarean section in a women with protein S deficiency and undiagnosed phaeochromocytoma
23. A common 4G allele in the promoter of the plasminogen activator inhibitor-1 (PAI-1) gene as a risk factor for pulmonary embolism and arterial thrombosis in hereditary protein S deficiency
24. Acute myocardial infarction with normal coronary artery: A case report and review of literature
25. Coronary thrombosis associated with inherited protein S deficiency: A case report
26. Reversible cardiogenic shock in an angry women-case report and review of the literature
27. Early coronary artery bypass graft thrombosis in a patient with protein S deficiency
28. Influence of protein S deficiency on the arterial thrombosis risk
29. Free protein S levels drop following myocardial infarction
30. Relationships between protein C, protein S, von Willebrand factor and euglobulin lysis time and cardiovascular risk factors in subjects with and without coronary heart disease
31. Plasma levels of protein C and protein S in patients with vasculopathy
32. Dietary oleic and palmitic acids and postprandial factor VII in middle-aged men heterozygous and homozygous for factor VII R353Q polymorphism
33. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens
34. New direct assay of free protein S antigen using two distinct monoclonal antibodies specific for the free form
35. Regression models and life-tables
36. Associations of protein C and protein S with serum lipid concentrations
37. Reevaluation of total, free and bound protein S and C4b-binding protein levels in plasma anticoagulated with citrate or hirudin
38. Serum cholesterol, blood pressure, and mortality: Implications from a cohort of 361662 men
39. Plasma triglyceride is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: A meta-analysis of population-based prospective studies
40. Serum apolipoprotein AI and B and lipoproteins in middle-aged men with and without previous myocardial infarction
41. Atherosclerosis - An inflammatory disease
42. Cytokines in normal and pathogenic inflammatory states
43. Endothelial cell protein S synthesis is upregulated by the complex of IL-6 and soluble IL-6 receptor
44. IL-6 upregulates protein S expression in the HepG-2 hepatoma cells
45. Tumour necrosis factor - A downregulates protein S secretion in human microvascular and umbilical vein endothelial cells but not in the Hep G-2 hepatoma cell line
46. Activation of coagulation releases endothelial cell mitogens
47. Selective inhibitory effects of the anticoagulant activated protein C on the responses of human mononuclear phagocytes to LPS, IFN-gamma, or phorbol ester
48. The up-regulation of IL-6 and IL-8 in human endothelial cells by activated protein C
49. The contribution of thrombosis to the clinical expression of coronary atherosclerosis
50. A CCA/CCG neutral dimorphism in the codon for Pro 626 in the human protein S gene alpha (PROS1)
51. Two new frequent dimorphisms in the protein S (PROS1) gene
52. Genetic modulation of plasma protein S levels by two frequent dimorphisms in the PROS1 gene
53. Heerlen polymorphism of protein S, an immunologic polymorphism due to dimorphism of residue 460
54. The Ser 460 to Pro substitution of the protein S alpha (PROS1) gene is a frequent mutation associated with free protein S (type IIa) deficiency
55. Immunonephelometric determination of C4b-binding protein
56. Determination of serum levels of complement component C4b-binding protein: Influence of age and inflammation
57. Differential regulation of alpha and beta chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S